BEAM offering history
Every offering-related filing in Beam Therapeutics Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 512 filings back to Aug 9, 2018.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 3, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 10, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 10, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Mar 10, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 28, 2024 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Oct 31, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 10, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 7, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 10, 2021 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Apr 1, 2021 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Apr 1, 2021 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Apr 1, 2021 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Apr 1, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 23, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 19, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 1, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 30, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 28, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Feb 7, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Feb 5, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 5, 2020 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Feb 5, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 31, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 27, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 17, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 27, 2019 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
BEAM offering FAQ
When did BEAM last execute an offering?
Per SEC filings, Beam Therapeutics Inc.'s most recent priced offering document is a 8-K filed 2025-07-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did BEAM last announce or register an offering?
The most recent registration is a S-3ASR filed 2024-02-28. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.